New Jersey A 1789: Provides that sterile syringe access programs are inherently beneficial uses.

Status: Introduced, Referred to Assembly Health Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: A 1789

Sponsors: Verrelli, Anthony S.

View New Jersey A 1789 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.